摘要
目的分析在慢阻肺急性加重期中使用糖皮质激素和特布他林联合治疗的临床效果。方法此次选择硬币法将2017年12月至2018年12月诊治的68例慢阻肺急性加重期患者进行分组,参照组(n=34)行特布他林单独治疗,观察组(n=34)行糖皮质激素和特布他林联合治疗,计算参照组和观察组的治疗差异。结果观察组慢阻肺急性加重期患者临床治疗合计值、PaCO2、PaO2、FVC、FEV1均显著优于参照组数据,P<0.05,有统计学数据论证意义。结论将糖皮质激素和特布他林联合治疗用于治疗慢阻肺急性加重期中具有显著作用。
Objective To analyze clinical effect of glucocorticoid combined with terbutaline in treatment of acute exacerbation stage chronic obstructive pulmonary disease. Methods Choose 68 cases acute exacerbation stage chronic obstructive pulmonary disease patients from December 2017 to December 2018, divide them into two groups with coin casting method. Control group(n =34) was treated with terbutaline alone, and observation group(n =34) with glucocorticoid combined with terbutaline. Calculate treatment difference between control group and observation group. Results Total clinical treatment value, PaCO2, PaO2, FVC and FEV1 in observation group was significantly better than control group(P<0.05). Conclusion Glucocorticoid combined with terbutaline has significant effect in treatment of acute exacerbation stage COPD.
作者
周滢滢
王晶莹
李丽
ZHOZU Ying-ying;WANG Jing-ying;LI Li(Daqing Oil Field General Hospital,Daqing,Heilongjiang,163000)
出处
《智慧健康》
2019年第30期130-131,共2页
Smart Healthcare
关键词
糖皮质激素
特布他林
慢阻肺急性
Glucocorticoid
Terbutaline
Acute Stage of Chronic Obstructive Pulmonary Disease
